Effects of Vibrational Therapy on Pelvic Floor Muscle Strength and Tone in Healthy Women
Effects of Mechanical Vibration Applied to the Pelvic Floor Musculature: A Quasi-Experimental Study
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This quasi-experimental study aims to evaluate the effects of mechanical vibration applied to the pelvic floor musculature in healthy women aged 18-45. The intervention involves vibrational therapy targeting the central fibrous nucleus of the perineum, with the goal of assessing changes in muscle tone, strength, and biomechanical properties. The study will also examine the tolerance to this technique, with data collected at baseline and after 8 weeks of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 27, 2026
March 1, 2026
4 months
March 20, 2026
March 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pelvic floor muscle tone
The tone of the pelvic floor muscles will be measured using the MyotonPro® device, which assesses the frequency of oscillation (Hz) of the muscle. The tone will be evaluated at baseline and post-intervention to determine any changes resulting from the vibrational therapy.
Baseline (before intervention) and Post-intervention (after 8 weeks of treatment).
Secondary Outcomes (4)
Pelvic floor muscle strength
Baseline (before intervention) and Post-intervention (after 8 weeks of treatment).
Biomechanical properties of pelvic floor musculature
Baseline (before intervention) and Post-intervention (after 8 weeks of treatment)
Pelvic floor dysfunction impact
Baseline (before intervention) and Post-intervention (after 8 weeks of treatment).
Tolerance to the vibration therapy
Throughout the intervention (ongoing during each session) and Post-intervention (after 8 weeks of treatment).
Study Arms (3)
High frequency vibration group
EXPERIMENTALParticipants in this group will receive mechanical vibration applied to the central fibrous nucleus of the perineum at a frequency of 138 Hz. The treatment will be administered twice a week for 8 weeks, with each session lasting 20 minutes. The primary aim is to evaluate the effects of high-frequency vibration on the tone, strength, and biomechanical properties of the pelvic floor muscles.
Moderate frequency vibration group
ACTIVE COMPARATORParticipants in this group will receive mechanical vibration applied to the central fibrous nucleus of the perineum at a frequency of 41.5 Hz. The treatment will be administered twice a week for 8 weeks, with each session lasting 20 minutes. The focus is to assess the effects of moderate-frequency vibration on the muscle tone, strength, and biomechanical parameters of the pelvic floor musculature
Low frequency vibration group
EXPERIMENTALParticipants in this group will receive mechanical vibration applied to the central fibrous nucleus of the perineum at a frequency of 24.9 Hz. The treatment will be administered twice a week for 8 weeks, with each session lasting 20 minutes. The goal is to evaluate how low-frequency vibration impacts the pelvic floor muscle tone, strength, and biomechanical properties compared to the other groups.
Interventions
z. The treatment will be administered twice a week for 8 weeks, with each session lasting 20 minutes. The primary aim is to evaluate the effects of high-frequency vibration on the tone, strength, and biomechanical properties of the pelvic floor muscles.
Participants in this group will receive mechanical vibration applied to the central fibrous nucleus of the perineum at a frequency of 41.5 Hz. The treatment will be administered twice a week for 8 weeks, with each session lasting 20 minutes. The focus is to assess the effects of moderate-frequency vibration on the muscle tone, strength, and biomechanical parameters of the pelvic floor musculature
Participants in this group will receive mechanical vibration applied to the central fibrous nucleus of the perineum at a frequency of 24.9 Hz. The treatment will be administered twice a week for 8 weeks, with each session lasting 20 minutes. The goal is to evaluate how low-frequency vibration impacts the pelvic floor muscle tone, strength, and biomechanical properties compared to the other groups.
Eligibility Criteria
You may qualify if:
- Throughout the intervention (ongoing during each session) and Post-intervention (after 8 weeks of treatment).
You may not qualify if:
- \. Urogenital Infections: Presence of any active urogenital infections. 2. Abdominal or Pelvic Surgery: History of abdominal or pelvic surgery. 3. Active Menstruation: Women who are menstruating at the time of the study. 4. Breastfeeding: Participants who are actively breastfeeding. 5. Mictrurition Symptoms: Presence of any urinary symptoms. 6. Pain: Pain upon palpation of the central fibrous nucleus of the perineum. 7. Sensory Alterations: Presence of altered sensitivity such as hypoalgesia, hyperalgesia, or allodynia.
- \. Spinal Lesions: History of spinal cord injuries. 9. Neurological Conditions: Any neurological disorders. 10. Pelvic Organ Prolapse: Diagnosed prolapse of pelvic organs. 11. Obesity: Body Mass Index (BMI) ≥ 30 kg/m². 12. Active Oncology Treatment: Any current or recent cancer treatments. 13. Pregnancy: Women who are pregnant. 14. Pelvic Floor Pathologies: Diagnosed pelvic floor dysfunctions. 15. Ongoing Pelvic Floor Treatment: Participants currently receiving active pelvic floor treatments.
- \. Dermatological Pathologies: Any active vulvar dermatological conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Lee J, Lee K, Song C. Determining the Posture and Vibration Frequency that Maximize Pelvic Floor Muscle Activity During Whole-Body Vibration. Med Sci Monit. 2016 Oct 27;22:4030-4036. doi: 10.12659/msm.898011.
PMID: 27787476RESULTRodrigues MP, Paiva LL, Ramos JGL, Ferla L. Vibratory perineal stimulation for the treatment of female stress urinary incontinence: a systematic review. Int Urogynecol J. 2018 Apr;29(4):555-562. doi: 10.1007/s00192-017-3444-y. Epub 2017 Aug 15.
PMID: 28812109RESULTBarassi G, Bellomo RG, Frondaroli F, Frondaroli S, Santarelli A, Di Felice PA, Supplizi M, Palermo T, Saggini R. Integrated Rehabilitation Approach with Manual and Mechanic-Acoustic Vibration Therapies for Urinary Incontinence. Adv Exp Med Biol. 2019;1211:41-50. doi: 10.1007/5584_2019_436.
PMID: 31468357RESULT
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
March 20, 2026
First Posted
March 27, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03